Insulin Drug Makers Shed Antitrust Claims In MDL
By Khorri Atkinson · July 12, 2021, 5:34 PM EDT
Novo Nordisk Inc., CVS Health Corp. and other drugmakers and pharmacy benefit managers partially secured their bid to escape claims, at least for now, that they colluded to drive up insulin...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login